TickerFacts.

Marimed Inc. (MRMD): Long-Term Debt

Annual figures by period end, from SEC filings.

$76.04M
As of 2025-12-31
$82.67M
As of 2026-06-30
+15.7%
5-year compound annual growth
$78.19M2018-12-31: $14.97M2019-12-31: $36.28M2020-12-31: $36.71M2024-12-31: $78.19M2025-12-31: $76.04M$76.04M
2018-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$76.04M-2.7%2026-03-12, Balance as of period end
2024-12-31$78.19Mn/a2025-03-06, Balance as of period end
No annual figure between 2020-12-31 and 2024-12-31.
2020-12-31$36.71M+1.2%2021-03-23, Balance as of period end
2019-12-31$36.28M+142.4%2020-04-01, Balance as of period end
2018-12-31$14.97Mn/a2019-04-16, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
Marimed Inc. (MRMD)2025-12-31$76.04M-2.7%
Glass House Brands Inc. (GLAS)2025-12-31$68.67M+18.0%
biote Corp. (BTMD)2025-12-31$103.12M-5.7%
Mannatech Inc (MTEX)2025-12-31$2.75Mn/a
Jushi Holdings Inc. (JUSH)2025-12-31$205.83M+10.5%
Fitlife Brands, Inc. (FTLF)2024-12-31$13.12M-34.8%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$319.52M+3.7%
Cyanotech Corp (CYAN)2025-03-31$4.71M-13.7%
Trulieve Cannabis Corp. (TRLV)2025-12-31$136.74M-62.5%

Compare MRMD, GLAS, BTMD, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗